Back
Alnylam Pharmaceuticals Stock Price Chart
Free Report: 7 Nuclear Stocks Set to Rise
Grab your copy now!
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
7 Day Trial
ALL ACCESS PASS
$
7
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 257.74 | Buy |
| 20-day SMA: | 249.75 | Buy |
| 50-day SMA: | 257.54 | Buy |
| 200-day SMA: | 251.5 | Buy |
| 8-day EMA: | 263.89 | Buy |
| 20-day EMA: | 256.08 | Buy |
| 50-day EMA: | 255.39 | Buy |
| 200-day EMA: | 243.44 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.72 | Buy |
| Relative Strength Index (14 RSI): | 71.41 | Buy |
| Chaikin Money Flow: | -979016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.44 - 263) | Buy |
| Bollinger Bands (100): | (240.32 - 271.8) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 290.70 while ALNY 8-day simple moving average is 257.74, which is a Buy signal.
-
The stock price of ALNY is 290.70 while Alnylam Pharmaceuticals 20-day SMA is 249.75, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day simple moving average is 257.54 while ALNY share price is 290.70, making it a Buy technically.
-
ALNY stock price is 290.70 and Alnylam Pharmaceuticals 200-day simple moving average is 251.50, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a BuyThe current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
37.6B
Price in USD:
290.70
Share Volume:
1.8M
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 290.70 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is not overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 290.70 while ALNY 8-day exponential moving average is 263.89, which is a Buy signal.
-
The stock price of ALNY is 290.70 while Alnylam Pharmaceuticals 20-day EMA is 256.08, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 255.39 while ALNY share price is 290.70, making it a Buy technically.
-
ALNY stock price is 290.70 and Alnylam Pharmaceuticals 200-day simple moving average is 243.44, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is 3.72, suggesting Alnylam Pharmaceuticals is a Buy
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 71.41, which suggest Alnylam Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (238.44 - 263), which suggest Alnylam Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (240.32 - 271.8), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.